Compartilhar
Informação da revista
Vol. 44. Núm. 2.
Páginas 303-304 (Abril - Junho 2022)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 44. Núm. 2.
Páginas 303-304 (Abril - Junho 2022)
Images in Clinical Hematology
Open Access
Megakaryocytes in pulmonary circulation: an “old” knowledge with new implications
Visitas
3929
Leonardo Rodrigues de Oliveira
Autor para correspondência
leonardo.oliveira@ebserh.gov.br

Correspondence author: Rua Getúlio Guaritá, 130, 38025-440 Uberaba, MG, Brazil +55-34-33185046
, Antônio Carlos de Oliveira Meneses
Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, MG, Brazil
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (3)
Mostrar maisMostrar menos
Texto Completo

The post-mortem pulmonary findings of a 59-year-old woman with infection by the human immunodeficiency virus and liver cirrhosis related to chronic hepatitis B are presented. The patient was admitted due to decompensated liver disease and initial laboratory data revealed anemia (hemoglobin concentration 8.8 g/dL), leukocytosis (12 × 106/L) and normal platelet count (399 × 109/L). The patient was receiving prolonged highly active antiretroviral therapy. No treatment directed at chronic hepatitis B, tuberculosis or anti-cancer therapy has been administered.

In post-mortem study, hemoperitoneum was identified as the immediate cause of death in association with active pulmonary tuberculosis and hepatitis B virus-associated hepatocarcinoma (TNM Staging System – IVB). Numerous megakaryocytes were detected in pulmonary circulation (Figures 1 and 2). In bone marrow evaluation, mycobacterial or fungal infections as well as cancer infiltration were not detected (Figure 3). The evidence of thrombopoiesis in lungs is not recent and innovative experiments indicate that up to half of platelet production may originate from megakaryocytes located in the pulmonary circulation.1,2,3

Figure 1.

Multiple megakaryocytes (arrows) identified in the pulmonary circulation (Hematoxylin and Eosin staining, 400 × magnification).

(0,36MB).
Figure 2.

Immunohistochemistry analysis for confirmation of megakaryocytes (arrows) in lungs. Factor VIII-related antigen stain. CD61 immunohistochemistry was also positive on megakaryocytes (not shown). 400 × magnification.

(0,37MB).
Figure 3.

Bone marrow biopsy shows normal global cellularity (granulocytic hypoplasia and erythroid hyperplasia) and normal megakaryocyte cellularity (2.8 megakaryocytes per high-power field [× 400] – normal range 2 to 4 per high-power field). There is no evidence of cancer infiltration, granulomas, or mycoses (Hematoxylin and Eosin staining, 200 × magnification).

(0,35MB).
References
[1]
RF Levine, A Eldor, PK Shoff, S Kirwin, D Tenza, EM. Cramer.
Circulating megakaryocytes. Delivery of large numbers of intact, mature megakaryocytes to the lungs.
Eur J Haematol, 51 (1993), pp. 233-246
[2]
E Lefrançais, G Ortiz-Muñoz, A Caudrillier, B Mallavia, F Liu, DM Sayah, et al.
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors.
Nature, 544 (2017), pp. 105-109
[3]
I Borges, I Sena, P Azevedo, J Andreotti, V Almeida, A Paiva, et al.
Lung as a niche for hematopoietic progenitors.
Stem Cell Rev, 13 (2017), pp. 567-574
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas